ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,463.50
      -1.66%
      US Tech 100
      18,659.60
      -2.94%
      Dow Jones
      40,069.06
      -0.72%
      Brent Oil
      81.305
      0.66%
      Bitcoin
      66,469.32
      0.83%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Carbios (ALCRB) Quote

      Carbios

      Carbios (ALCRB)

      EU
      20.65
      0.50
      (2.48%)
      Closed July 24 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      20.65
      Bid
      20.30
      Ask
      20.70
      Volume
      11,901
      20.05 Day's Range 20.65
      17.88 52 Week Range 28.85
      Market Cap
      347.862M
      Previous Close
      20.15
      Open
      20.20
      Last Trade
      54
      @
      20.65
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      27,103
      Shares Outstanding
      16,845,630
      Dividend Yield
      -
      PE Ratio
      -12.78
      Earnings Per Share (EPS)
      -1.62
      Revenue
      59k
      Net Profit
      -27.22M

      About Carbios

      Sector
      Chemicals & Chem Preps, Nec
      Industry
      Chemicals & Chem Preps, Nec
      Website
      www.carbios.com
      Headquarters
      Clermont-ferrand, Puy-de-dome, Fra
      Founded
      1970
      Carbios is listed in the Chemicals & Chem Preps sector of the Euronext with ticker ALCRB. The last closing price for Carbios was 20.15 €. Over the last year, Carbios shares have traded in a share price range of 17.88 € to 28.85 €.

      Carbios currently has 16,845,630 shares outstanding. The market capitalization of Carbios is 339.44 € million. Carbios has a price to earnings ratio (PE ratio) of -12.78.

      ALCRB Latest News

      More News

      New Nature publication confirms CARBIOS’ leadership in enzymatic degradation of plastic

      CARBIOS and Toulouse Biotechnology Institute (TBI) publish groundbreaking article that presents enzyme optimization work leading to an enzyme-embedded PLA able to disintegrate and biodegrade in...

      July 17 2024
      GlobeNewswire Inc.

      Une nouvelle publication dans Nature confirme l’avance de CARBIOS dans la dégradation enzymatique du plastique

      Une nouvelle publication dans Nature confirme l’avance de CARBIOS dans la dégradation enzymatique du plastique CARBIOS et Toulouse Biotechnology Institute (TBI) publient un article présentant les...

      July 17 2024
      UK Regulatory

      Nature-Publikation untermauert CARBIOS' Expertise im Bereich des enzymatischen Abbaus von Kunststoffen

      Nature-Publikation untermauert CARBIOS' Expertise im Bereich des enzymatischen Abbaus von Kunststoffen CARBIOS und das Toulouse Biotechnology Institute veröffentlichen einen wegweisenden...

      July 17 2024
      UK Regulatory

      Report on Carbios’ liquidity contract with Natixis ODDO BHF

      Report on Carbios’ liquidity contract with Natixis ODDO BHF PRESS RELEASE   REGULATED INFORMATION: ONGOING Report on Carbios’ liquidity contract with Natixis ODDO BHF Shares concerned: Carbios...

      July 09 2024
      UK Regulatory

      Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF

      Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF COMMUNIQUÉ DE PRESSE   INFORMATION REGLEMENTEE : PERMANENTE CARBIOS : Bilan semestriel du contrat de liquidité confié à Natixis...

      July 09 2024
      UK Regulatory

      CARBIOS et Zhink Group entament des discussions officielles en vue d'un partenariat à long terme visant à installer des capacités industrielles de biorecyclage du PET en Chine, dans la perspective d'un premier accord de licence portant sur

      CARBIOS et Zhink Group entament des discussions officielles en vue d'un partenariat à long terme visant à installer des capacités industrielles de biorecyclage du PET en Chine, dans la...

      June 27 2024
      GlobeNewswire Inc.

      CARBIOS and TOMRA Textiles join forces to scale circularity of polyester textiles

      CARBIOS and TOMRA Textiles will collaborate to close the textiles circularity gap between collection of textile waste and innovative technologies for textile-to-textile recycling...

      June 18 2024
      GlobeNewswire Inc.

      Carbios und TOMRA Textiles: Partnerschaft zur Förderung der Kreislauffähigkeit von Polyestertextilien

      Carbios und TOMRA Textiles: Partnerschaft zur Förderung der Kreislauffähigkeit von Polyestertextilien Die Kooperation von CARBIOS und TOMRA schließt die Lücke in der Textilkreislaufwirtschaft...

      June 18 2024
      GlobeNewswire Inc.

      L'OCCITANE en Provence und CARBIOS präsentieren Kunststoffflakon aus enzymatisch recyceltem PET - das Ergebnis einer europäischen Kooperation für eine Kreislaufwirtschaft

      L'OCCITANE en Provence und CARBIOS präsentieren Kunststoffflakon aus enzymatisch recyceltem PET - das Ergebnis einer europäischen Kooperation für eine Kreislaufwirtschaft L'OCCITANE en...

      May 30 2024
      GlobeNewswire Inc.

      CARBIOS und Hündgen schließen Liefervereinbarung für die weltweit erste PET-Biorecycling-Anlage

      CARBIOS und Hündgen schließen Liefervereinbarung für die weltweit erste PET-Biorecycling-Anlage    CARBIOS und Hündgen schließen Liefervereinbarung für die weltweit erste...

      May 02 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.552.7363184079620.120.819.641849020.30211409DE
      40.914.6099290780119.7422.519.642384420.98187888DE
      12-2.6-11.182795698923.2526.2519.62710322.49306654DE
      26-3.1-13.052631578923.7526.9517.882799722.42321437DE
      52-5.85-22.075471698126.528.8517.882784823.09981354DE
      156-21.35-50.83333333334246.3817.882479930.30290844DE
      26013.99210.060060066.6661.85.523352830.47691677DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NUZENuZee Inc
      $ 3.19
      (209.71%)
      		96.75M
      DRMADermata Therapeutics Inc
      $ 2.75
      (111.54%)
      		57.18M
      PIRSPieris Pharmaceuticals Inc
      $ 14.49
      (81.58%)
      		5.19M
      QXOQXO Inc
      $ 128.25
      (61.73%)
      		152.34k
      BBLGBone Biologics Corporation
      $ 1.93
      (54.40%)
      		37.47M
      NXTTNext Technology Holding Inc
      $ 2.79
      (-52.06%)
      		754.99k
      NUWENewellis Inc
      $ 2.48
      (-40.24%)
      		877.64k
      VWEVintage Wine Estates Inc
      $ 0.069746
      (-37.67%)
      		21.91M
      CJETChijet Motor Company Inc
      $ 3.29
      (-35.24%)
      		327.41k
      CONNConns Inc
      $ 0.3332
      (-34.28%)
      		3.23M
      SLNASelina Hospitality PLC
      $ 0.034
      (30.77%)
      		944.16M
      SGMOSangamo Therapeutics Inc
      $ 0.566
      (41.04%)
      		218.57M
      NVDANVIDIA Corporation
      $ 116.415
      (-5.04%)
      		149.56M
      SQQQProShares UltraPro Short QQQ
      $ 8.925
      (9.11%)
      		117.79M
      TSLATesla Inc
      $ 221.0425
      (-10.28%)
      		114.02M

      Discussion

      View Full Feed
      nyt nyt 3 minutes ago
      Your assumption that his or anyone else's words are there to influence your opinions, shows that you are narrow minded. Are your expressed opinions here designed to influence anyone......or are they just your desire to express your opinions, regardless of who they do or don't influence? And does you
      VPLM
      Hawk05 Hawk05 3 minutes ago
      All BS till it’s not….
      BIEL
      otc37 otc37 3 minutes ago
      Interesting how a barrage of PR's were released on UK newswires. As it stands , VXIT ihas exclusive marketing rights for North America for Maxclean and it looks like they want to penetrate european/global markets. This could be bigger than we thought.
      VXIT
      blackhawks blackhawks 3 minutes ago
      Well how about an Occam's Razo take? THE catalyst for what subsequently unfolded was Biden's debate performance.

      Sure, there had been rumblings about Biden's frail movements and random gaffes. But the debate was an opportunity not to be blown.

      Still, the groundswell had
      stressfreeliving stressfreeliving 3 minutes ago
      $HIRU NEWS coming shortly.
      HIRU
      EyeInTheSky EyeInTheSky 4 minutes ago
      rsi looking good, nice cool off day. Everyone needs rest days even stocks 😁
      HIRU
      $Green$ $Green$ 4 minutes ago
      Get ready to dump if you can
      SPY
      Oleblue Oleblue 4 minutes ago
      Sometimes, you never know the potential of a stock in the beginning, but things only get better as time goes on.

      Platform overview

      Palantir AIP powers real-time, AI-driven decision-making in the most critical commercial and government contexts around the world. From pub
      PLTR
      pinkslipjunkie pinkslipjunkie 4 minutes ago
      Ha!...you got that right!...why!...because EMGE is our baby...that is why...;-)
      And I fckin wonder lol why on Apollo Biowellness website they only show news from emge:)
      https://apollobiowellness.com/in-the-news/
      EMGE
      dexprs dexprs 4 minutes ago
      The SPX due to its recent pullback is within 50 points of its 10 week EMA. The 30 week is still further and I am keeping an eye on it at 5156. Today.
      RobotDroid RobotDroid 4 minutes ago
      News ain't coming anytime soon, so expect the stock to drop like a rock in the sea, and nothing but silence from magagement.
      NWBO
      LVerstee LVerstee 4 minutes ago
      He can buy time if he presents the proof to RD that funds are pending in BoA account.
      ITUP
      zab zab 4 minutes ago
      J D Vance wrote the forward for a book coming out by the Heritage Foundation on Project 2025. Trump owns it.
      .
      ducci1 ducci1 4 minutes ago
      There we go ----SPX 15 min MACD Makin the turn !
      SPY
      jedijazz jedijazz 5 minutes ago
      $CBDW Investors can register for an exclusive event, hosted by RedChip Companies, which will feature CBDW's CEO Austen Lambrecht, who will share insight into the Company's innovative product portfolio and near-term expansion plans.

      To register for the free webinar, please visit: https
      CBDW
      jedijazz jedijazz 5 minutes ago
      $CBDW Investors can register for an exclusive event, hosted by RedChip Companies, which will feature CBDW's CEO Austen Lambrecht, who will share insight into the Company's innovative product portfolio and near-term expansion plans.

      To register for the free webinar, please visit: https
      CBDW
      gdog gdog 5 minutes ago
      nice jop flipping so many i lost track of SLS
      SLS
      boston745 boston745 5 minutes ago
      It should because of the harm cell phones cause due to EM radiation; same problem with EVs however Evs should increase the exposure compared to cellphones. Cellphones and metal implants do not go together. Cellphones obviously expose the user to EM radiation and metal implants amplify the effect the
      TSLA
      exwannabe exwannabe 6 minutes ago
      Yes, it was a request but you’d have a difficult time explaining why this wouldn’t be considered an unmet medical need, which would fall under the 150 day process.
      That is not the MHRA rule. The 150 day is for "high quality marketing authorization applications".
      NWBO
      LVerstee LVerstee 6 minutes ago
      Wake up! Laxmi is not going to solve our problems. Based on your response, it appears you are within his inner circle, so please convey a message to him.

      He must pay the wages of the Indian worker who has medical bills to cover.

      I am indifferent to whether he has to sel
      ITUP
      mzasif mzasif 6 minutes ago
      $HIRU .0038 Huge Liftoff coming!
      HIRU
      Viking61 Viking61 6 minutes ago
      Sammy, we’re a long way from your .43 prediction.
      FNMA
      Dj56 Dj56 6 minutes ago
      So many people cannot, at their present level of knowledge, engage in talking with Dr. Lippa or others of his educational and experiential esteem, that to give a true update to retail investors such as we, would require too much time away from achieving productive gain in the medical science they ar
      RSPI
      Twilson Twilson 6 minutes ago
      Spy -100 trying small call position

      Your Recent History

      EU
      ALCRB
      Carbios
      BIT
      P1Q6Q6
      BNP Paribas Issuance
      Delayed Upgrade Clock